We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Incisionless Surgery Shows Promise in Prostate Cancer Treatment

By HospiMedica International staff writers
Posted on 16 Aug 2010
A new surgical procedure for the treatment of prostate cancer uses surgical instruments inserted through the penis, signaling the next step in the evolution of minimally invasive surgery. More...


Researchers at the Mayo Clinic (Scottsdale, AZ, USA) have developed special tools to allow natural orifice transluminal endoscopic surgical (NOTES) removal of the prostate, naming the procedure NOTES radical prostatectomy (NOTES RP). The instruments are inserted through the urethra, and an innovative technique is used to remove the entire prostate. Surgeons then rejoin the internal tissues via specialized instruments that are also designed to work through the urethra. Patients benefit from the procedure because there are no incisions, little risk of bleeding, and are usually able to leave the hospital within 24 hours.

The procedure involves a 100 W holmium:yttrium-aluminum-garnet laser with a 550 μm end-firing laser fiber, a 26F resectoscope, a 7F laser stabilizing catheter, and continuous irrigation. The surgeons first radically resect the prostate with the lasers; the tissue is then removed endoscopically with a tissue morcellator and delivered into the bladder. The first patient to undergo the NOTES RP procedure at the Mayo Clinic was released in June 2010, and suffered no complications throughout any part of the operation.

"The reason this hasn't been done in prostate surgery before is because of the challenge of rejoining or suturing the bladder back to the urethra,” said urologist Mitchell Humphreys, M.D., of the Mayo Clinic. "This really shows that the impossible is now possible, and represents a paradigm shift not only in the way we look at diseases, but also how we surgically treat disease.”

Standard surgical therapy for prostate cancer--one of the most commonly diagnosed malignancies in men--involves removal of the prostate through open, laparoscopic, or robot-assisted laparoscopic means. Each of these approaches involves removes the entire prostate, and presumably the cancer, and then suturing the bladder back to the urethra to restore the continuity of the urinary system.

Related Links:
Mayo Clinic


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.